Symbols / AVCT
AVCT Chart
About
No company description available for this symbol.
Fundamentals
Scroll to Statements| Sector | — | Industry | — | Market Cap | — |
| Enterprise Value | — | Income | — | Sales | — |
| Book/sh | — | Cash/sh | — | Dividend Yield | — |
| Payout | — | Employees | — | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | — | P/B | — | P/C | — |
| EV/EBITDA | — | EV/Sales | — | Quick Ratio | — |
| Current Ratio | — | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | — | EPS next Y | — | EPS Growth | — |
| Revenue Growth | — | Earnings | — | ROA | — |
| ROE | — | ROIC | — | Gross Margin | — |
| Oper. Margin | — | Profit Margin | — | Shs Outstand | — |
| Shs Float | — | Short Float | — | Short Ratio | — |
| Short Interest | — | 52W High | — | 52W Low | — |
| Beta | — | Avg Volume | — | Volume | — |
| Target Price | — | Recom | — | Prev Close | — |
| Price | — | Change | — |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
—
Simplified FCF or EPS-based estimate
Ratings
No analyst ratings or price targets available.
- Avacta Group (LON:AVCT) Stock Price Up 7.5% - Should You Buy? - MarketBeat ue, 24 Feb 2026 11
- With 75% institutional ownership, Avacta Group Plc (LON:AVCT) is a favorite amongst the big guns - Yahoo Finance Sun, 15 Feb 2026 08
- Avacta Group (LON:AVCT) Stock Crosses Below Two Hundred Day Moving Average - Here's Why - MarketBeat Fri, 13 Feb 2026 08
- Avacta Lifts Dosing Cap and Sets Path to Efficacy Trials for Faridoxorubicin - TipRanks Mon, 02 Feb 2026 08
- Avacta Therapeutics (AIM: AVCT) Preliminary Data in Faridoxorubicin Phase 1b Trial - Share Talk Mon, 08 Dec 2025 08
- With 83% institutional ownership, Avacta Group Plc (LON:AVCT) is a favorite amongst the big guns - Yahoo Finance Mon, 08 Sep 2025 07
- Avacta Group (LON:AVCT) Stock Price Down 14.6% - Here's Why - MarketBeat Wed, 17 Dec 2025 08
- Why Avacta Group plc Shares Are Under Pressure - TipRanks Mon, 20 Oct 2025 07
- Avacta Therapeutics (AIM: AVCT) Appoints Francis Wilson as Chief Scientific Officer - Share Talk Mon, 09 Feb 2026 08
- Avacta Names Strand Hanson as Nominated Adviser and Updates Share Capital and Governance Disclosures - TipRanks Mon, 19 Jan 2026 08
- Avacta Group (LON:AVCT) Share Price Passes Above 200-Day Moving Average - What's Next? - MarketBeat hu, 05 Feb 2026 08
- Avacta Therapeutics (AIM: AVCT) Presents preclinical data at AACR-NCI-EORTC - Share Talk Mon, 27 Oct 2025 07
- Avacta Group Raises £16 Million to Advance Oncology Programs - TipRanks Sun, 19 Oct 2025 07
- Avacta Therapeutics (AIM: AVCT) reports new AVA6103 pharmacology data - Share Talk hu, 18 Dec 2025 08
- Avacta Group Announces Preliminary Data in Salivary Gland Cancer Trial - TipRanks Sun, 07 Dec 2025 08
Insider Transactions
No recent insider transactions.
Financials
No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for AVCT
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|